1Sang KG,Koehnke R,Caldwell JR,.Low dose long-term corticosteroid therapy in rheumatoid arthritis:An analysis of serious adverse events[J].Am J Med,1994,96(2):115-123.
2Lukert BP,Kream BE.Clinical and basic aspects of glucocorticoid action in bone.In:Bilezikian JP,Raisz LG,Rodan GA,editors.Principles of bone biology,San Diego[M].CA:Academic Press.1996.533-548.
3Kim N,Odgren PR,Kim DK,.Diverse role of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene[J].Proc Natl Acad Sci USA,2000,97(20):10 905-10 910.
4Bekker PJ,Holloway D,Nalanishi A,et al.Osteoprotegerin(OPG)has potent and sustained anti-resorptive activity in postmenopausal women[J].J Bone Miner Res,1999,14(Suppl):180.
5Kostenuik PJ,Capparelli C,Morony S,et al.OPG and PTH-(1-34)have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats[J].Endocrinology,2001,142 (10):4295-4 304.
6Hofbauer LC,Lacey DL,Dunstan CR,et al.Interleukin-1 beta and tumor necrosis factor-alpha,but not interleukin-6,stimulate osteoprotegerin ligand gene expression in human osteoblastic cells[J].Bone,1999,25 (3):255-259.
7Weinstein RS,Chen JR,Powers CC,.Promotion of osteoclast survival and antagonism of bisphosrhonate-induced osteoclast apoptosis by glucccorticoids[J].J Clin Invest,2002,109(8):1 041-1048.
8Dalle Carbonare L,Arlot ME,Chavassieux PM,.Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis[J].J Bone Miner Res,2001,16 (1):97-103.
9Sasali N,Kusano E,Ando Y,.Changes in osteoprotegerin and markers of bone metabolism during glucocorticoid treatment in patients with chronic-glumerulonephritis[J].Bone,2002,30 (6):853-858.
10Hirayama T,Sabokbar A,Athanasou NA.Effect of corticosteroids on human osteoclast formation and activity[J].J Endocrinol,2002,175(1):155-163.
8Wechsler B, Huong Du LT, Piette JC.Is there a role for antithrombotic therapy in the prevention of pregnancy loss[J]. Haemostasis, 1999, 29 (supplesl) : 112 - 120.
9Harger JH, Laifer SA, Bontempo FA. Low- dose aspirin and prednisone treatment of pregnancy loss caused by lupus anticoagulants[J]. J Perinatol, 1995,15(6) :463 - 469.
10Sipak-Szmigiel O, Ronin-wqlknowska E, Miklaszwicz A, et al. Application of intravenous immunogiobulin therapy (IVIG) in pregnant patients with recurrent spontaneous abortions[ J]. 2003,74(5) : 350 - 355.
